Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Open-label, Safety and Proof-of-concept Study to Assess Safety, Tolerability and Efficacy of AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)

Trial Profile

A Multicenter, Open-label, Safety and Proof-of-concept Study to Assess Safety, Tolerability and Efficacy of AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jan 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Retinal oedema
  • Focus Adverse reactions; Proof of concept; Registrational
  • Acronyms ORION-1
  • Sponsors Aerie Pharmaceuticals

Most Recent Events

  • 01 Jan 2023 Results published in the Retina.
  • 04 Nov 2021 According to an Aerie Pharmaceuticals media release, topline results from this trial were presented at the 39th Annual Scientific Meeting of the American Society of Retina Specialists 2021.
  • 06 Oct 2021 According to an Aerie Pharmaceuticals media release, topline results from this trial will be presented at the 39th Annual Scientific Meeting of the American Society of Retina Specialists 2021.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top